Skip to main content
. 2018 Nov 16;6:347. doi: 10.3389/fped.2018.00347

Table 6.

Median abundance of antibiotic resistance genes among infants in each group.

Antibiotic resistance genes (ARG) encoding Classes of ARG 7 days (n = 60 fecal samples) 28 days (n = 64 fecal samples) 4 months (n = 60 fecal samples)
PEP NPVP FTC P FDR Q PEP NPVP FTC P FDR Q PEP NPVP FTC P FDR Q
(n = 20) (n = 30) (n = 10) (n = 24) (n = 31) (n = 9) (n = 24) (n = 29) (n = 7)
Class A Beta lactamase 0.61 4.2* 0.00* 0.001 0.020 0.00 0.00 0.00 0.080 0.586 1.43 1.0 0.00 0.443 1.327
Class C Beta lactamase 0.00 0.00 0.20 0.126 0.229 0.98 0.22 0.00 0.492 0.812 9.1 12.7 9.5 0.605 1.134
Aminoglycoside acetyltransferase 0.00 0.00 0.00 0.202 0.311
Aminoglycoside phosphotransferase 0.00 0.00 0.00 0.590 0.653 0.00 0.16 0.00 0.114 0.497
Aminoglycoside nucleotidyltransferase 0.00 0.00 0.00 0.765 0.765 0.00 0.00 0.00 0.296 0.426 0.00 0.00 0.00 0.584 0.814
Tetracycline efflux 0.00 0.00* 0.00 0.015 0.050 0.00 0.00 0.00 0.173 0.423 0.00 0.00 0.00 0.174 1.949
Tetracycline ribosomal protection 0.00 0.26 4.4* 0.047 0.118 0.52 3.7 1.77 0.397 0.615 6.4 23.4 23.4 0.407 1.041
Quinolone resistance 9.0 21.6 5.3 0.062 0.138 9.81 7.6 0.77 0.133 0.470 9.2 9.4 7.1 0.501 1.186
Macrolide/MLS resistance 0.00 0.00 0.00 0.757 0.797
ABC efflux pump 0.13 1.15 0.25 0.206 0.294 1.06 1.35 0.06* 0.013 0.414 0.70 0.96 0.83 0.766 0.887
RND antibiotic efflux 5.2 41.9* 38.4 0.034 0.097 37.7 53.7 4.1 0.170 0.683 94.0 116.7 90.3 0.674 0.936
MFS antibiotic efflux 1.16 113.3 29.0 0.339 0.342 85.8 119.1 16.0 0.056 0.489 105.2 119.5 84.7 0.614 0.839
Multidrug efflux pump activity 0.00 24.6 1.92 0.337 0.449 20.9 21.7 4.9 0.346 0.478 10.0 14.0 8.1 0.616 1.552
Multidrug resistance efflux pump 0.00 0.00 0.00 0.668 0.742 0.00 0.00 0.00 0.603 0.678 0.18 0.00 0.60 0.496 0.819
Gene modulating antibiotic efflux 5.6 41.0** 0.76 0.012 0.060 14.7 20.1 0.34 0.163 0.376 19.7 27.7 27.5 0.645 0.871
SMR antibiotic efflux 1.2 0.00 0.00 0.00 0.914 0.932
Chloramphenicol acetyltransferase 0.00 0.00 0.00 0.071 0.142
Antibiotic target 0.48 0.00 0.00** 0.013 0.052 0.00 0.00 0.00 0.266 0.396 0.00 0.00 0.00 0.720 0.768
Gene modulating resistance 53.5 8.1** 39.2 0.003 0.030 37.6 27.8 44.6 0.419 0.419 37.5 45.8 46.2 0.678 1.286
rRNA methyltransferase 0.00 10.6 10.6 0.128 0.213 6.0 8.8 1.72 0.008 0.464 4.1 5.4 4.4 0.665 0.887
Other ARG 5.3 16.7** 2.02 0.011 0.073 7.3 8.4 0.26 0.132 0.413 7.2 10.5 6.3 0.613

Numbers are presented as median total reads normalized by the total number of reads in each fecal sample.

Antibiotic resistance genes analyzed using ShortBRED.

PEP, probiotic extremely preterm infants; NPVP, non-probiotic very preterm infants; FTC, full-term control; FDR, false discovery rate.

Comparisons between all three treatment groups by nonparametric Kruskal–Wallis test.

Post-hoc comparisons by non-parametric Mann–Whitney U-test (vs. PEP) (**P < 0.01, *P < 0.05).

Comparison between different time points by generalized linear model with a Poisson family (†P < 0.05).

Genes modulating antibiotic efflux: norA, baeR, marA, phoQ, ramA, soxR. Genes modulating resistance: WblE, WhiB. Other ARG: bacA.

Bold indicates significant differences in median abundance of antibiotic resistance genes between the three groups (P- and Q-value).